Literature DB >> 24470394

Germline disruption of Pten localization causes enhanced sex-dependent social motivation and increased glial production.

Amanda K Tilot1, Mary K Gaugler2, Qi Yu2, Todd Romigh2, Wanfeng Yu2, Robert H Miller3, Thomas W Frazier4, Charis Eng5.   

Abstract

PTEN Hamartoma Tumor Syndrome (PHTS) is an autosomal-dominant genetic condition underlying a subset of autism spectrum disorder (ASD) with macrocephaly. Caused by germline mutations in PTEN, PHTS also causes increased risks of multiple cancers via dysregulation of the PI3K and MAPK signaling pathways. Conditional knockout models have shown that neural Pten regulates social behavior, proliferation and cell size. Although much is known about how the intracellular localization of PTEN regulates signaling in cancer cell lines, we know little of how PTEN localization influences normal brain physiology and behavior. To address this, we generated a germline knock-in mouse model of cytoplasm-predominant Pten and characterized its behavioral and cellular phenotypes. The homozygous Pten(m3m4) mice have decreased total Pten levels including a specific drop in nuclear Pten and exhibit region-specific increases in brain weight. The Pten(m3m4) model displays sex-specific increases in social motivation, poor balance and normal recognition memory-a profile reminiscent of some individuals with high functioning ASD. The cytoplasm-predominant protein caused cellular hypertrophy limited to the soma and led to increased NG2 cell proliferation and accumulation of glia. The animals also exhibit significant astrogliosis and microglial activation, indicating a neuroinflammatory phenotype. At the signaling level, Pten(m3m4) mice show brain region-specific differences in Akt activation. These results demonstrate that differing alterations to the same autism-linked gene can cause distinct behavioral profiles. The Pten(m3m4) model is the first murine model of inappropriately elevated social motivation in the context of normal cognition and may expand the range of autism-related behaviors replicated in animal models.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24470394      PMCID: PMC4030776          DOI: 10.1093/hmg/ddu031

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  55 in total

1.  Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis.

Authors:  Ji-Hyun Chung; Charis Eng
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

2.  Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein.

Authors:  Ji-Hyun Chung; Margaret E Ginn-Pease; Charis Eng
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

3.  Control of dendritic arborization by the phosphoinositide-3'-kinase-Akt-mammalian target of rapamycin pathway.

Authors:  Jacek Jaworski; Samantha Spangler; Daniel P Seeburg; Casper C Hoogenraad; Morgan Sheng
Journal:  J Neurosci       Date:  2005-12-07       Impact factor: 6.167

4.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

5.  Differentiation of the O-2A progenitor cell line CG-4 into oligodendrocytes and astrocytes following transplantation into glia-deficient areas of CNS white matter.

Authors:  R J Franklin; S A Bayley; R Milner; C Ffrench-Constant; W F Blakemore
Journal:  Glia       Date:  1995-01       Impact factor: 7.452

6.  Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations.

Authors:  M G Butler; M J Dasouki; X-P Zhou; Z Talebizadeh; M Brown; T N Takahashi; J H Miles; C H Wang; R Stratton; R Pilarski; C Eng
Journal:  J Med Genet       Date:  2005-04       Impact factor: 6.318

7.  Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo.

Authors:  Melissa M Fraser; Xiaoyan Zhu; Chang-Hyuk Kwon; Erik J Uhlmann; David H Gutmann; Suzanne J Baker
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

8.  Pten regulates neuronal arborization and social interaction in mice.

Authors:  Chang-Hyuk Kwon; Bryan W Luikart; Craig M Powell; Jing Zhou; Sharon A Matheny; Wei Zhang; Yanjiao Li; Suzanne J Baker; Luis F Parada
Journal:  Neuron       Date:  2006-05-04       Impact factor: 17.173

Review 9.  Cancer phenomics: RET and PTEN as illustrative models.

Authors:  Kevin M Zbuk; Charis Eng
Journal:  Nat Rev Cancer       Date:  2006-12-14       Impact factor: 60.716

10.  Neuroglial activation and neuroinflammation in the brain of patients with autism.

Authors:  Diana L Vargas; Caterina Nascimbene; Chitra Krishnan; Andrew W Zimmerman; Carlos A Pardo
Journal:  Ann Neurol       Date:  2005-01       Impact factor: 10.422

View more
  36 in total

1.  An Integrated Deep-Mutational-Scanning Approach Provides Clinical Insights on PTEN Genotype-Phenotype Relationships.

Authors:  Taylor L Mighell; Stetson Thacker; Eric Fombonne; Charis Eng; Brian J O'Roak
Journal:  Am J Hum Genet       Date:  2020-05-21       Impact factor: 11.025

Review 2.  The Role of PTEN in Neurodevelopment.

Authors:  Patrick D Skelton; Radu V Stan; Bryan W Luikart
Journal:  Mol Neuropsychiatry       Date:  2020-01-21

Review 3.  Sex Differences in Autism Spectrum Disorder: a Review.

Authors:  Sarah L Ferri; Ted Abel; Edward S Brodkin
Journal:  Curr Psychiatry Rep       Date:  2018-03-05       Impact factor: 5.285

Review 4.  PTEN-opathies: from biological insights to evidence-based precision medicine.

Authors:  Lamis Yehia; Joanne Ngeow; Charis Eng
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

5.  Germline PTEN mutations are associated with a skewed peripheral immune repertoire in humans and mice.

Authors:  Ritika Jaini; Matthew G Loya; Alexander T King; Stetson Thacker; Nicholas B Sarn; Qi Yu; George R Stark; Charis Eng
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

Review 6.  Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder.

Authors:  Amanda K Tilot; Thomas W Frazier; Charis Eng
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

Review 7.  Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links.

Authors:  S W Hulbert; Y-H Jiang
Journal:  Neuroscience       Date:  2015-12-28       Impact factor: 3.590

8.  Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles.

Authors:  Eejung Kim; Nina Ilic; Yashaswi Shrestha; Lihua Zou; Atanas Kamburov; Cong Zhu; Xiaoping Yang; Rakela Lubonja; Nancy Tran; Cindy Nguyen; Michael S Lawrence; Federica Piccioni; Mukta Bagul; John G Doench; Candace R Chouinard; Xiaoyun Wu; Larson Hogstrom; Ted Natoli; Pablo Tamayo; Heiko Horn; Steven M Corsello; Kasper Lage; David E Root; Aravind Subramanian; Todd R Golub; Gad Getz; Jesse S Boehm; William C Hahn
Journal:  Cancer Discov       Date:  2016-05-04       Impact factor: 39.397

Review 9.  Defective phosphoinositide metabolism in autism.

Authors:  Christina Gross
Journal:  J Neurosci Res       Date:  2016-07-04       Impact factor: 4.164

Review 10.  PTEN Mouse Models of Cancer Initiation and Progression.

Authors:  Yu-Ru Lee; Pier Paolo Pandolfi
Journal:  Cold Spring Harb Perspect Med       Date:  2020-02-03       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.